TumorDiagnostik & Therapie 2009; 30(5): 275-278
DOI: 10.1055/s-0028-1109793
Thieme Onkologie aktuell

© Georg Thieme Verlag KG Stuttgart · New York

Pankreaskarzinom auf dem Boden eines intraduktal papillär-muzinösen Tumors

Carcinoma of the Pancreas at the Site of an Intraductal Papillary Mucinous NeoplasiaA. J. Fieger1 , N. Demmel1 , D. F.-X. Mündel1 , R. M. Schenck1 , T. Harnisch2 , N. C. Nüssler1
  • 1Klinik für Allgemein-, Viszeralchirurgie, endokrine Chirurgie und Coloproktologie
  • 2Institut für Pathologie, Klinikum Neuperlach, Städtisches Klinikum München GmbH
Further Information

Publication History

Publication Date:
19 October 2009 (online)

Zusammenfassung

Intraduktal papillär-muzinöse Tumore (IPMT) des Pankreas sind intraduktal gelegene, Muzin-produzierende, zystische Tumore des Pankreas mit malignem Potenzial. Wir berichten über den Fall einer 54-jährigen Frau, die aufgrund eines nicht-invasiven IPMT einer Pankreassegmentresektion unterzogen wurde. Die Resektatränder des Operationspräparates waren tumorfrei. Drei Jahre später fiel im Rahmen einer Nachuntersuchung eine hochgradig malignitätsverdächtige Raumforderung im Pankreasschwanz auf, woraufhin eine Pankreasschwanzresektion durchgeführt wurde. Histologisch zeigte sich ein Adenokarzinom. Anzunehmen ist in diesem Fall die Entwicklung eines Pankreaskarzinoms auf dem Boden eines nicht-invasiven IPMT. Dieser Fall wirft erneut die Frage auf, wie ausgedehnt nicht-invasive IPMT des Pankreas reseziert werden sollen. 

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are intraductally located, mucin-producing cystic neoplasms of the pancreas with a malignant potential. We report about a 54-year-old female who underwent segmental resection of the pancreas for non-invasive IPMN. The surgical margins were tumour-negative. Three years later a highly suspicious tumour of the pancreatic tail was detected during routine follow-up. Resection of the pancreatic tail was performed. The histological analysis revealed an adenocarcinoma. This case suggests the development of a pancreatic carcinoma from a non-invasive IPMN and raises the question about the extent of surgery of non-invasive IPMNs of the pancreas. 

Literatur

  • 1 Adsay N V. The ”new kid on the block”: Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.  Surgery. 2003;  133 459-463
  • 2 Adsay N V. Cystic neoplasia of the pancreas: pathology and biology.  J Gastrointest Surg. 2008;  12 401-404
  • 3 Bernard P, Scoazec J Y, Joubert M et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases.  Arch Surg. 2002;  137 1274-1278
  • 4 Chari S T, Yadav D, Smyrk T C et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.  Gastroenterology. 2002;  123 1500-1507
  • 5 Dobrowolski F, Saeger H D. Die Therapie gutartiger Tumoren des Pankreas.  Zentralbl Chir. 2003;  128 424-428
  • 6 Doi R, Fujimoto K, Wada M et al. Surgical management of intraductal papillary mucinous tumor of the pancreas.  Surgery. 2002;  132 80-85
  • 7 Kitagawa Y, Unger T A, Taylor S et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas.  J Gastrointest Surg. 2003;  7 12-18
  • 8 Klöppel G, Solcia E, Longnecker D S et al. Histological Typing of Tumors of the Exocrine Pancreas. Berlin: Springer; 1996: 1 – 61
  • 9 Maire F, Hammel P, Terris B et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.  Gut. 2002;  51 717-722
  • 10 Matsumoto T, Aramaki M, Yada K et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas.  J Clin Gastroenterol. 2003;  36 261-265
  • 11 Nagai K, Doi R, Kida A et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection.  World J Surg. 2008;  32 271-278
  • 12 Nakagohri T, Kinoshita T, Konishi M et al. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.  Ann Surg Oncol. 2007;  14 3174-3180
  • 13 Ohashi K, Murakami Y, Maruyama M et al. Four cases of ”mucin-producing” cancer of the pancreas on specific findings of the papilla of Vater [in Japanese].  Prog Dig Endosc. 1982;  20 348-351
  • 14 Pelaez-Luna M, Chari S T, Smyrk T C et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients.  Am J Gastroenterol. 2007;  102 1759-1764
  • 15 Rivera J A, Fernandez-Del Castillo C, Pins M et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.  Ann Surg. 1997;  225 637-644
  • 16 Salvia R, Fernandez-Del Castillo C, Bassi C et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.  Ann Surg. 2004;  239 678-685
  • 17 Sohn T A, Yeo C J, Cameron J L et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.  Ann Surg. 2004;  239 788-797
  • 18 Sohn T A, Yeo C J, Cameron J L et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.  Ann Surg. 2001;  234 313-321
  • 19 Sohn T A, Yeo C J, Cameron J L et al. Resected adenocarcinoma of the pancreas – 616 patients: results, outcomes, and prognostic indicators.  J Gastrointest Surg. 2000;  4 567-579
  • 20 Spinelli K S, Fromwiller T E, Daniel R A et al. Cystic pancreatic neoplasms: observe or operate.  Ann Surg. 2004;  239 651-657
  • 21 Tanaka M, Chari S, Adsay V et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.  Pancreatology. 2006;  6 17-32
  • 22 Tanaka M, Chari S, Capella C et al. Histological Typing of Tumors of the Exocrine Pancreas.  Pancreatology. 2006;  6 17-32
  • 23 Traverso L W. Surgical treatment of intraductal papillary mucinous neoplasms of the pancreas: the aggressive approach.  J Gastrointest Surg. 2002;  6 662-663
  • 24 Traverso L W, Peralta E A, Ryan Jr J A et al. Intraductal neoplasms of the pancreas.  Am J Surg. 1998;  175 426-432
  • 25 Wada K, Kozarek R A, Traverso L W. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.  Am J Surg. 2005;  189 632-636
  • 26 Wiesenauer C A, Schmidt C M, Cummings O W et al. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.  Arch Surg. 2003;  138 610-617

A. J. Fieger

Klinik für Allgemein-, Viszeralchirurgie, endokrine Chirurgie und Coloproktologie Klinikum Neuperlach Städtisches Klinikum München GmbH

Oskar-Maria-Graf-Ring 51

81737 München

Phone: + 49 / 89 / 67 94 25 01

Fax: + 49 / 89 / 67 94 25 17

Email: alexander_fieger@yahoo.de

    >